Citric Acid, Brand Name : Alkamax (200 ml), CAS No. : 77-92-9

We are offering citric acid. composition: rhepo, citric acid buffer solution and human serum albumin as stabilizer. indications: treatment of anemia of chronic renal failure patients, including patients on dialysis and patients not on dialysis treatment of anemia in cancer patients on chemotherapy reduction of allogeneic blood transfusion in surgery patients usage and dosage (for treatment of renal anemia): rhepo should be used under instruction of physicians. It may be administrated subcutaneously or intravenously, 2-3 times per week. The dosage should be adjusted according to the severity of anemia, age and other related factors. The following dosage is for reference: treatment period: the initial dose is 100-150iu/kg per week for patients on hemodialysis and 75-100 iu/kg for patients not on hemodialysis. If hematocrit increases less than 0.5vol% weekly the dose can be increased by 15-30iu/kg 4 weeks after the initial dose, but the increased maximum dose is not more than 30iu/kg /week. The hematocrit should be increased within the range of 30-33vol%, but not higher than 34vol%. maintenance period: when hematocrit has reached to 30-33vol% or hemoglobin has reached to 100-110g/l, maintenance period starts. The dosage in this period shall be adjusted to the 2/3 of the recommended dosage in the treatment period. The hematocrit shall be monitored once every 2-4 weeks to adjust the dosage so as to maintain the hematocrit and hemoglobin at the proper level, at the same time to avoid erythropoiesis too quickly. intravenous administration is recommended for patients on hemodialysis and subcutaneous administration for patients on peritoneal dialysis and not on dialysis.